ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →
Thursday, 12 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Kabra Drugs Ltd

NSE: KABRADG · BSE: 524322 · Pharmaceuticals & Biotechnology · 32 announcements

Share price
₹18.15
Market cap
₹43.03 Cr
Revenue (annual)
₹92.74 Cr
Net profit (annual)
₹4.96 Cr
P/E (TTM)
5.6×Sector 43.8×
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

16:03 IST BSE
Other Announcement

Kabra Drugs Other Announcement

Kabra Drugs Limited has submitted its quarterly compliance certificate for the period ended March 31, 2026, as per SEBI regulations. The Registrar and Share Transfer Agent, Skyline Financial Services, confirmed that physical share certificates received for dematerialization were duly verified, mutilated, and cancelled within 15 days.